Exposure of a pyrethroid-susceptible strain of bed bugs, Cimex lectularius L. (Hemiptera: Cimicidae) to varying concentrations of deltamethrin for 24 h indicated no significant difference in mortality between males, females, and nymphs at 24 nor at 168 h postexposure when bed bugs were removed to untreated surfaces at 24 h. In addition, many bed bugs classified as morbid or moribund at 24 h and removed to untreated surfaces at this time, recovered by 336 h (2 wk) and were capable of feeding when given the opportunity. Adult female bed bugs that survived were able to lay eggs and the resulting nymphs blood-fed. By contrast, all bed bugs classified as morbid or moribund at 24 h that remained on deltamethrin-treated surfaces for 336 h either died or were still classified as morbid or moribund at the end of this time. No bed bugs classified as morbid or moribund blood-fed when given the opportunity at 2 wk, regardless of whether they remained on the treated surfaces or were removed to untreated surfaces. A power analysis demonstrated we would have detected even moderate differences in mortality between males and females, had differences existed. Therefore, using males exclusively in efficacy assays is a suitable strategy to preserve females for laboratory colony purposes. Results also indicated there is little reason to assess efficacy beyond 1 wk, even when bed bugs are exposed for only 24 h.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 106 • No. 2